Shorted
Integral Diagnostics logo

IDX

Integral Diagnostics

Health Care Equipment & Services

Integral Diagnostics is a leading provider of medical imaging services in Australia and New Zealand, offering a comprehensive range of diagnostic imaging services. The company is known for its advanced technology and skilled radiologists, ensuring high-quality patient care and accurate diagnostics.

Shorted

short percentage2.98%
reported shorts11.1M
shares on issue372.927M

About

industry

Health Care Equipment & Services

address

Suite 9.02, Level 9, 45 William Street, MELBOURNE, VIC, AUSTRALIA, 3000

Key Metrics

market cap
$898.75M
p/e ratio120.50
eps$0.02
dividend yield271.00%

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Medical Imaging
Australia
New Zealand
Healthcare Services
ASX

Company Overview

AI-generated company summary

Integral Diagnostics is a leading provider of medical imaging services in Australia and New Zealand, offering a comprehensive range of diagnostic imaging services. The company is known for its advanced technology and skilled radiologists, ensuring high-quality patient care and accurate diagnostics.

Company History

Integral Diagnostics was founded to provide high-quality diagnostic imaging services across Australia. Over the years, the company has expanded its operations into New Zealand, becoming one of the largest radiology providers in the region. Key milestones include strategic acquisitions and partnerships that have strengthened its market position and service offerings.

Competitive Advantages

Integral Diagnostics leverages cutting-edge imaging technology and a team of highly skilled radiologists to deliver superior diagnostic services. Its strategic presence in both Australia and New Zealand allows it to serve a broad patient base, enhancing its market reach and operational efficiency.

Risk Factors

  • Regulatory changes in healthcare
  • Technological advancements by competitors
  • Economic downturn affecting healthcare spending

Recent Developments

Last 6 months

Integral Diagnostics has recently focused on expanding its service capabilities through technology upgrades and strategic partnerships, enhancing its diagnostic accuracy and service delivery.

Financial Reports

20 reports available

Appendix 4E and FY25 Annual Report

Annual ResultsAug 26, 2025via asx_announcements

FY25 Half Year Results App4D and Interim Report

Half Year ResultsFeb 26, 2025via asx_announcements

FY25 Half Year Results Media Release

Half Year ResultsFeb 26, 2025via asx_announcements

FY25 Half Year Results Investor Presentation

Half Year ResultsFeb 26, 2025via asx_announcements

IDX FY25 Half Year Results Release Date and Conference Call

Half Year ResultsJan 21, 2025via asx_announcements

Appendix 4E and FY24 Annual Report

Annual ResultsAug 27, 2024via asx_announcements

Half Yearly Report and Accounts

Half Year ResultsFeb 20, 2024via asx_announcements

Half Year Results Media Release

Half Year ResultsFeb 20, 2024via asx_announcements

Half Year Results Investor Presentation

Half Year ResultsFeb 20, 2024via asx_announcements

FY24 IDX Half Year Results Release Date and Conference Call

Half Year ResultsJan 18, 2024via asx_announcements

Showing 10 of 20 reports